Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

NCT00068432 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Celecoxib
DRUG: Gemcitabine Hydrochloride

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]